The United States Anti-Drug Agency (USADA) announced on Mar. 8, that light-heavyweight fighter Ion Cutelaba (13-3-0, 1NC) has been sanctioned a six-month suspension for declaring the use of Ozone Therapy on his control paperwork on out-of-competition tests on Oct. 18 and Oct. 19, 2017.
According to the USADA press release, “Ozone therapy is a treatment that can be administered in a variety of methods, some of which are prohibited under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.”
USADA further states that the organization “contacted the athlete to request more information about the route of administration in order to establish whether the treatment was permissible. Cutelaba’s physician subsequently provided documentation indicating that the treatment was administered on October 3, 2017, and October 17, 2017, in a prohibited manner, as it involved a blood transfusion. The WADA Prohibited List prohibits the administration or reintroduction of blood or red blood cell products of any origin or quantity in the circulatory system, unless a valid Therapeutic Use Exemption has been obtained. While Cutelaba was unaware of the violation and declared the treatment on his doping control paperwork, he was unable to refute the documentation provided.”
Cutelaba’s suspension was accordingly reduced to six months from the usual two-year period in consideration of Cutelaba’s voluntary admission of the violation as well as his degree of fault. His period of eligibility began on Nov. 3, 2017, which meant he was removed from the UFC 217 card that was held on Nov. 4, 2017.
“The Hulk’s” last bout was a knockout win over Henrique da Silva (13-3-0, 1NC) at UFC Fight Night 110 in June 2017.